Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Neuropeptide Y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease.

Masoudi-Kazemabad A, Jamialahmadi K, Moohebati M, Mojarrad M, Manshadi RD, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M.

Angiology. 2013 Jan;64(1):40-5. doi: 10.1177/0003319711435149. Epub 2012 Feb 3.

PMID:
22308535
2.

High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease.

Masoudi-Kazemabad A, Jamialahmadi K, Moohebati M, Mojarrad M, Dehghan-Manshadi R, Forghanifard MM, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M.

Gene. 2012 Mar 15;496(1):22-7. doi: 10.1016/j.gene.2012.01.002. Epub 2012 Jan 24.

PMID:
22289186
3.

Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease.

Parizadeh SA, Jamialahmadi K, Rooki H, Zaim-Kohan H, Mirhafez SR, Hosseini N, Mohiti-Ardakani J, Moohebati M, Masoudi-Kazemabad A, Ferns GA, Ghayour-Mobarhan M.

Ann Hum Biol. 2015 Mar;42(2):178-83. doi: 10.3109/03014460.2014.916750. Epub 2014 Jun 4.

PMID:
24897239
4.

Risk of obesity and type 2 diabetes with tumor necrosis factor-α 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects.

Sobti RC, Kler R, Sharma YP, Talwar KK, Singh N.

Mol Cell Biochem. 2012 Jan;360(1-2):1-7. doi: 10.1007/s11010-011-0917-z. Epub 2011 Nov 13.

PMID:
22081334
5.

Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.

Pettersson-Fernholm K, Karvonen MK, Kallio J, Forsblom CM, Koulu M, Pesonen U, Fagerudd JA, Groop PH; FinnDiane Study Group.

Diabetes Care. 2004 Feb;27(2):503-9.

PMID:
14747236
6.

A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States.

Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, Cramer J, Southwick S, Charney D, Krystal J, Gelernter J.

Arch Gen Psychiatry. 2002 Sep;59(9):825-31.

PMID:
12215082
7.

Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population.

Sabouri S, Ghayour-Mobarhan M, Moohebati M, Hassani M, Kassaeian J, Tatari F, Mahmoodi-kordi F, Esmaeili HA, Tavallaie S, Paydar R, Sahebkar A, Tehrani SO, Ferns G, Behravan J.

ScientificWorldJournal. 2011 Jan 5;11:93-101. doi: 10.1100/tsw.2011.3.

8.

Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.

Ilveskoski E, Viiri LE, Mikkelsson J, Pörsti I, Lehtimäki T, Karhunen PJ.

Atherosclerosis. 2008 Aug;199(2):445-50. Epub 2007 Dec 4.

PMID:
18054939
9.

Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.

Nordman S, Ding B, Ostenson CG, Kärvestedt L, Brismar K, Efendic S, Gu HF.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):282-7.

PMID:
15926114
10.

The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population.

Tangurek B, Ozer N, Sayar N, Terzi S, Yilmaz H, Dayi SU, Ciloglu F, Aksu H, Asilturk R, Cagil A.

Heart Vessels. 2006 Sep;21(5):285-90. Epub 2006 Sep 29.

PMID:
17151815
11.

Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration.

Kaarniranta K, Holopainen JM, Karvonen MK, Koulu M, Kallio J, Pesonen U, Teräsvirta M, Uusitalo H, Immonen I.

Acta Ophthalmol Scand. 2007 Mar;85(2):188-91.

12.

Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.

Safranow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D.

Scand J Clin Lab Invest. 2009;69(1):102-12. doi: 10.1080/00365510802430964.

PMID:
18855224
13.

Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.

Salminen M, Lehtimäki T, Fan YM, Vahlberg T, Kivelä SL.

Public Health Nutr. 2008 Nov;11(11):1156-62. doi: 10.1017/S1368980008001717. Epub 2008 Feb 18.

PMID:
18279562
14.

Human C-reactive protein gene polymorphism and metabolic syndrome are associated with premature coronary artery disease.

Abd El-Aziz TA, Mohamed RH.

Gene. 2013 Dec 15;532(2):216-21. doi: 10.1016/j.gene.2013.09.042. Epub 2013 Sep 19.

PMID:
24055729
15.

The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I.

PLoS One. 2014 Sep 5;9(9):e106816. doi: 10.1371/journal.pone.0106816. eCollection 2014.

16.

PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.

Sjöholm LK, Melas PA, Forsell Y, Lavebratt C.

J Affect Disord. 2009 Nov;118(1-3):124-30. doi: 10.1016/j.jad.2009.02.009. Epub 2009 Mar 4.

PMID:
19264362
17.

Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.

Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MI.

Mol Genet Metab. 2002 Mar;75(3):260-4.

PMID:
11914038
18.

Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.

Niskanen L, Karvonen MK, Valve R, Koulu M, Pesonen U, Mercuri M, Rauramaa R, Töyry J, Laakso M, Uusitupa MI.

J Clin Endocrinol Metab. 2000 Jun;85(6):2266-9.

PMID:
10852461
19.

The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy.

Jaakkola U, Pesonen U, Vainio-Jylhä E, Koulu M, Pöllönen M, Kallio J.

Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):147-52.

PMID:
16705546
20.

Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.

Jaakkola U, Koulu M, Karvonen MK, Seppälä H, Pesonen U, Vahlberg T, Kallio J.

Exp Clin Endocrinol Diabetes. 2007 May;115(5):281-6.

PMID:
17516289
Items per page

Supplemental Content

Write to the Help Desk